Indication
Diabetic Ketoacidosis
6 clinical trials
7 products
2 drugs
Clinical trial
Balanced Multi-electrolyte Solution Versus 0.9% Sodium Chloride as Fluid Therapy for Patients Presenting With Moderate to Severe Diabetic KetoacidosisStatus: Not yet recruiting, Estimated PCD: 2026-04-01
Product
Plasma-Lyte 148Product
0.9% Sodium ChlorideClinical trial
Early Administration of Insulin Glargine in Patients With Diabetic KetoacidosisStatus: Terminated, Estimated PCD: 2023-02-28
Product
Insulin GlargineClinical trial
Thiamine as Adjunctive Therapy for Diabetic KetoacidosisStatus: Recruiting, Estimated PCD: 2024-05-01
Product
ThiamineDrug
VarlilumabClinical trial
Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk (DaNGER)Status: Recruiting, Estimated PCD: 2024-06-06
Product
Genomics AnalysisClinical trial
A Randomized, Double-Blinded, Placebo-controlled, Single-center Phase 1 Pilot Study to Explore the Effect of DAPAglifozin and Stress ( i.v. ACTH) on the Development of DKA After Insulin Withdrawal in Adolescent and Adult Subjects With T1DStatus: Terminated, Estimated PCD: 2022-08-26
Drug
DapagliflozinProduct
PlaceboClinical trial
Comparison of a Low Dose to a Standard Dose of Insulin in Adult Diabetic Ketoacidosis in ICU to Reduce Metabolic Complications : a Randomized, Controlled StudyStatus: Recruiting, Estimated PCD: 2024-08-16
Product
Insulin